BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9142965)

  • 1. Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article.
    Strang P
    Acta Oncol; 1996; 35 Suppl 5():50-4. PubMed ID: 9142965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should bisphosphonates be standard therapy for bone pain?
    Paterson AH
    Support Care Cancer; 1997 May; 5(3):200-4. PubMed ID: 9176965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the use of bisphosphonates in breast cancer.
    Kanis JA
    Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for the relief of pain secondary to bone metastases.
    Wong R; Wiffen PJ
    Cochrane Database Syst Rev; 2002; 2002(2):CD002068. PubMed ID: 12076438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and breast carcinoma.
    Lipton A
    Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
    Jagdev SP; Purohit P; Heatley S; Herling C; Coleman RE
    Ann Oncol; 2001 Oct; 12(10):1433-8. PubMed ID: 11762816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
    Diel IJ; Solomayer EF; Bastert G
    Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates for metastatic bone pain.
    Body JJ
    Support Care Cancer; 1999 Jan; 7(1):1-3. PubMed ID: 9926966
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone and cancer: pathophysiology and treatment of metastases.
    Kanis JA
    Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effect of bisphosphonates in mice.
    Bonabello A; Galmozzi MR; Bruzzese T; Zara GP
    Pain; 2001 Apr; 91(3):269-275. PubMed ID: 11275384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study.
    Thürlimann B; Morant R; Jungi WF; Radziwill A
    Support Care Cancer; 1994 Jan; 2(1):61-5. PubMed ID: 8156259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
    Thürlimann B
    Ann Oncol; 1994; 5 Suppl 7():S45-7. PubMed ID: 7532993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates may be useful in treatment of bone metastases.
    Jones J
    J Natl Cancer Inst; 2001 Jul; 93(14):1052-3. PubMed ID: 11459865
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
    Glover D; Lipton A; Keller A; Miller AA; Browning S; Fram RJ; George S; Zelenakas K; Macerata RS; Seaman JJ
    Cancer; 1994 Dec; 74(11):2949-55. PubMed ID: 7525038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in prostate carcinoma.
    Adami S
    Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates: biological response modifiers in breast cancer.
    Paterson AH
    Clin Breast Cancer; 2002 Aug; 3(3):206-16; discussion 217-8. PubMed ID: 12196279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.